15:47 11.08.2008, From the Global Voice, official newspaper of the IAS convention. A long-Term Race new Drugs vs Resistance
Facing with a constantly mutating virus necessary to count with constant technological innovations. The new antiretorviral medication look for innovative...
15:25 11.08.2008, Top 10 HIV Clinical Developments of 2007/2008
David Alain Wohl,M.D. University of North Carolina A:IDS Research and Treatment Unit. From the IAS meeting Mexico City, August 3/August 8, 2008.
15:21 11.08.2008, A successful IAS conference by Pedro Cahn IAS Co-'Chair from Global Voice Friday August 9, 2008.
Pedro Cahn stated that AIDS 2008 ended suspiciously with good news. International AIDS conferences are full of copious and voiced discourses which help to create a consensus that in turn, is critical in joign forces.
15:13 11.08.2008, Immunopathogenic mechanisms underlying HIV/1 infections Ives Levy Professor Clinical Immunology France, From the IAS meeting in Mexico City August 3 August 8 2008.
HIV1 causes destruction of the immune system. In past years the disease course was based on largely assessment of viral load and CD4 positive T cells. However recent insights from studies in individuals infected with HIV1
15:12 11.08.2008, Markers of immune Activation Professor Yves Levy France \presented at \iAS August 3/August *, 2008.
The markers of immune activation and predictors or disease progressing are changing. CD4T cells and HIV/RNA levels are still important markers of immune activation and disease progression in recent years have come into pay.
15:10 11.08.2008, Effect of Highly Active Antiretroviral Therapy, HAART on the Immune System of HIV1 infected patients. Presented by Professor Yves Levy, France at the International AIDS Society, IAS, meeting.
By severely limiting viral replication HAART helps to diminish not only direct viral destruction of T cells but also HIV-1 antigenic stimulation,a key driver of immune activation.
15:08 11.08.2008, Dr. Peter Piot executive director
Dr. Peter Piot executive director of UNAIDS since its creation in l995 announced in June that he will leave his position as UNAIDS executive director...
14:42 11.08.2008, Designing and interpreting HIV non inferiority trials in Naive and Experienced Patients
Designing and interpreting HIV non-inferiority trials in Naive and Experienced Patients Andrew Hill and Caroline Sabin AIDS 2008, 913 to 921.
14:24 11.08.2008, Transition from Long-Term Nonprogression to HIV-
Transition from Long-Term Nonprogression to HIV-1 Disease Associated With Escape From Cellular Immune Control. Kemal, et al from New York State Department of Health, Albany, Ny et al. JACQ. Immune Defic Syndr. Vol. 48, No. 2, June 1, 2008
13:15 03.08.2008, NEW HIV CASES UNDERESTIMATED FOR A DECADE BY THE CDC
New HIV cases have been under counted for a more than a decade by the CDC
19:53 02.08.2008, HIV positive people have increased Risk of blood Clots. (JAID JULY 1st, 2008)
HIV positive people have increased Risk of blood Clots.